‘Doing The Right Thing’: The Complicated Business Of Prescription Drug Pricing

With pharmaceutical companies receiving a lot of attention over the skyrocketing costs of drugs, Novartis CEO Joseph Jimenez talks to The Washington Post. And after Turing's controversial price hike for an HIV drug made waves this week, NBC News reports on other similar cases in the industry.